PL2365975T3 - Pochodne imidazopirydyny, które hamują wydzielanie kwasu żołądkowego - Google Patents
Pochodne imidazopirydyny, które hamują wydzielanie kwasu żołądkowegoInfo
- Publication number
- PL2365975T3 PL2365975T3 PL09748823T PL09748823T PL2365975T3 PL 2365975 T3 PL2365975 T3 PL 2365975T3 PL 09748823 T PL09748823 T PL 09748823T PL 09748823 T PL09748823 T PL 09748823T PL 2365975 T3 PL2365975 T3 PL 2365975T3
- Authority
- PL
- Poland
- Prior art keywords
- secretion
- inhibit
- gastric acid
- imidazopyridine derivatives
- imidazopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20086158A FI20086158A0 (fi) | 2008-12-03 | 2008-12-03 | Imidatsopyridiinijohdannaiset |
| PCT/FI2009/050861 WO2010063876A1 (en) | 2008-12-03 | 2009-10-27 | Imidazopyridine derivatives which inhibit the secretion of gastric acid |
| EP09748823A EP2365975B1 (en) | 2008-12-03 | 2009-10-27 | Imidazopyridine derivatives which inhibit the secretion of gastric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2365975T3 true PL2365975T3 (pl) | 2013-08-30 |
Family
ID=40240558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09748823T PL2365975T3 (pl) | 2008-12-03 | 2009-10-27 | Pochodne imidazopirydyny, które hamują wydzielanie kwasu żołądkowego |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8669269B2 (pl) |
| EP (1) | EP2365975B1 (pl) |
| JP (2) | JP5702295B2 (pl) |
| KR (1) | KR101742328B1 (pl) |
| CN (1) | CN102239167B (pl) |
| AU (1) | AU2009324007B2 (pl) |
| BR (1) | BRPI0916475A2 (pl) |
| CA (1) | CA2744647C (pl) |
| CY (1) | CY1114038T1 (pl) |
| DK (1) | DK2365975T3 (pl) |
| ES (1) | ES2415894T3 (pl) |
| FI (1) | FI20086158A0 (pl) |
| HK (1) | HK1164277A1 (pl) |
| HR (1) | HRP20130476T1 (pl) |
| IL (1) | IL213242A (pl) |
| MX (1) | MX2011005769A (pl) |
| PL (1) | PL2365975T3 (pl) |
| PT (1) | PT2365975E (pl) |
| RU (1) | RU2509771C2 (pl) |
| SI (1) | SI2365975T1 (pl) |
| SM (1) | SMT201300066B (pl) |
| WO (1) | WO2010063876A1 (pl) |
| ZA (1) | ZA201104838B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20086158A0 (fi) * | 2008-12-03 | 2008-12-03 | Mikael Dahlstroem | Imidatsopyridiinijohdannaiset |
| CN106279151A (zh) * | 2015-06-26 | 2017-01-04 | 江苏太瑞生诺生物医药科技有限公司 | 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法 |
| KR101777971B1 (ko) | 2016-07-05 | 2017-09-12 | 제일약품주식회사 | 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도 |
| WO2021089580A1 (en) * | 2019-11-04 | 2021-05-14 | Cinclus Pharma Ag | Oral formulation of x842 |
| WO2023079093A1 (en) | 2021-11-05 | 2023-05-11 | Cinclus Pharma Holding AB (publ) | Polymorphs of the mesylate salt of linaprazan glurate |
| EP4426694A1 (en) | 2021-11-05 | 2024-09-11 | Cinclus Pharma Holding AB (publ) | Polymorphs of the hydrochloride salt of linaprazan glurate |
| WO2023184282A1 (en) | 2022-03-30 | 2023-10-05 | Guizhou Sinorda Biomedicine Co., Ltd | X842 formulation |
| KR102496869B1 (ko) * | 2022-07-29 | 2023-02-07 | 제일약품주식회사 | 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법 |
| WO2024149834A1 (en) | 2023-01-11 | 2024-07-18 | Cinclus Pharma Holding AB (publ) | Polymorphs of the hydrobromide salt of linaprazan glurate |
| WO2024149833A1 (en) | 2023-01-11 | 2024-07-18 | Cinclus Pharma Holding AB (publ) | Polymorphs of the maleic acid salt of linaprazan glurate |
| WO2024161317A1 (ko) * | 2023-02-01 | 2024-08-08 | 제일약품주식회사 | 약학적 제제, 이의 제조 방법, 및 정제용 조성물 |
| CN118415999A (zh) * | 2023-02-01 | 2024-08-02 | 安康尼克治疗有限公司 | 可注射组合物、包含其的药物制剂以及制备该组合物的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA81219B (en) | 1980-01-23 | 1982-01-27 | Schering Corp | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them |
| DE3269604D1 (en) | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| US4725601A (en) | 1985-06-04 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers |
| SE9801526D0 (sv) | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| SE0003186D0 (sv) | 2000-09-07 | 2000-09-07 | Astrazeneca Ab | New process |
| SE0102808D0 (sv) | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | New compounds |
| SE0301903D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound III with therapeutic effect |
| SE0301905D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | Novel imidazopyridine compound I with therapeutic effect |
| EP1974730A1 (en) * | 2003-11-03 | 2008-10-01 | AstraZeneca AB | Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
| JP2008536817A (ja) | 2005-03-24 | 2008-09-11 | グラクソ グループ リミテッド | 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体 |
| WO2007039464A1 (en) | 2005-09-22 | 2007-04-12 | Nycomed Gmbh | Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders |
| FI20086158A0 (fi) * | 2008-12-03 | 2008-12-03 | Mikael Dahlstroem | Imidatsopyridiinijohdannaiset |
-
2008
- 2008-12-03 FI FI20086158A patent/FI20086158A0/fi not_active Application Discontinuation
-
2009
- 2009-10-27 CA CA2744647A patent/CA2744647C/en active Active
- 2009-10-27 CN CN200980148444.7A patent/CN102239167B/zh active Active
- 2009-10-27 AU AU2009324007A patent/AU2009324007B2/en active Active
- 2009-10-27 US US13/132,564 patent/US8669269B2/en active Active
- 2009-10-27 RU RU2011124169/04A patent/RU2509771C2/ru active
- 2009-10-27 KR KR1020117015341A patent/KR101742328B1/ko active IP Right Grant
- 2009-10-27 WO PCT/FI2009/050861 patent/WO2010063876A1/en active Application Filing
- 2009-10-27 DK DK09748823.3T patent/DK2365975T3/da active
- 2009-10-27 MX MX2011005769A patent/MX2011005769A/es active IP Right Grant
- 2009-10-27 SI SI200930616T patent/SI2365975T1/sl unknown
- 2009-10-27 EP EP09748823A patent/EP2365975B1/en active Active
- 2009-10-27 JP JP2011539063A patent/JP5702295B2/ja active Active
- 2009-10-27 BR BRPI0916475A patent/BRPI0916475A2/pt not_active Application Discontinuation
- 2009-10-27 ES ES09748823T patent/ES2415894T3/es active Active
- 2009-10-27 PL PL09748823T patent/PL2365975T3/pl unknown
- 2009-10-27 PT PT97488233T patent/PT2365975E/pt unknown
-
2011
- 2011-05-31 IL IL213242A patent/IL213242A/en active IP Right Grant
- 2011-06-30 ZA ZA2011/04838A patent/ZA201104838B/en unknown
-
2012
- 2012-05-08 HK HK12104485.0A patent/HK1164277A1/xx unknown
-
2013
- 2013-05-29 HR HRP20130476AT patent/HRP20130476T1/hr unknown
- 2013-06-04 CY CY20131100442T patent/CY1114038T1/el unknown
- 2013-06-19 SM SM201300066T patent/SMT201300066B/xx unknown
-
2014
- 2014-02-19 US US14/183,852 patent/US8993589B2/en active Active
- 2014-12-05 JP JP2014246949A patent/JP2015063548A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130476T1 (hr) | Derivati imidazopiridina koji inhibiraju sekreciju želuäśane kiseline | |
| IL261526A (en) | Methods for the purification of deoxycholic acid | |
| ZA201203615B (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| IL215691A0 (en) | Carboxylic acid compound | |
| IL220211A0 (en) | Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives | |
| PL2137206T3 (pl) | Sposób wytwarzania kwasu tauroursodeoksycholowego | |
| IL219603A0 (en) | Imidazopyridine derivatives | |
| HK1166065A1 (en) | Process for the preparation of propionic acid derivatives | |
| EP2300467A4 (en) | NEW AND IMPROVED METHODS FOR THE MANUFACTURE OF PALIPERIDONE | |
| IL219138A0 (en) | Process for the preparation of 4-sulfinyl-pyrazole derivatives | |
| IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
| EP2296470A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING GASTRIC ACID SECRETION | |
| ZA200709852B (en) | Spiro-benzimidazoles as inhibitors of gastric acid secretion | |
| EP2157089A4 (en) | THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES | |
| GB2464854B (en) | Process for the preparation of risperidone | |
| EP2444401A4 (en) | NEW IMIDAZOPYRIDINE COMPOUND | |
| ZA201205062B (en) | Process for the preparation of propionic acid derivatives | |
| GB0601079D0 (en) | Measurement of gastric acid secretion | |
| SI2321312T1 (sl) | Postopek za pripravo paliperidona | |
| GB0904311D0 (en) | Processes for the preparation of compounds | |
| GB0814997D0 (en) | Processes for the preparation of compounds | |
| ZA201107562B (en) | Compound for the treatment of tuberculosis | |
| GB0906872D0 (en) | Amino acid derivatives | |
| GB0906202D0 (en) | Compounds for the treatment of neoplasia | |
| GB0908699D0 (en) | Compounds for the treatment of neoplasia |